
Drugs for Immunotherapy Global Market Report 2025
Description
Drugs for Immunotherapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on drugs for immunotherapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for drugs for immunotherapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drugs for immunotherapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Type: Monoclonal Antibodies; Interferons; Interleukins; Vaccines; Checkpoint Inhibitors; Other Types
2) By Therapy Area: Cancer; Autoimmune & Inflammatory Diseases; Infectious Diseases; Other Therapy Areas
3) By End User: Hospitals & Clinics; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Monoclonal Antibodies: Naked Monoclonal Antibodies; Conjugated Monoclonal Antibodies; Bispecific Monoclonal Antibodies
2) By Interferons: Interferon Alfa; Interferon Beta; Interferon Gamma
3) By Interleukins: Interleukin-2 (IL-2); Interleukin-6 (IL-6); Interleukin-12 (IL-12)
4) By Vaccines: Preventive Vaccines; Therapeutic Vaccines
5) By Checkpoint Inhibitors: PD-1 Inhibitors; PD-L1 Inhibitors; CTLA-4 Inhibitors
6) By Other Types: Cancer Cell Therapies; Cytokine Therapy; T-Cell Receptor Therapy
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Novartis AG; Amgen Inc.; AbbVie Inc.; Merck & Co. Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on drugs for immunotherapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for drugs for immunotherapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drugs for immunotherapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Type: Monoclonal Antibodies; Interferons; Interleukins; Vaccines; Checkpoint Inhibitors; Other Types
2) By Therapy Area: Cancer; Autoimmune & Inflammatory Diseases; Infectious Diseases; Other Therapy Areas
3) By End User: Hospitals & Clinics; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Monoclonal Antibodies: Naked Monoclonal Antibodies; Conjugated Monoclonal Antibodies; Bispecific Monoclonal Antibodies
2) By Interferons: Interferon Alfa; Interferon Beta; Interferon Gamma
3) By Interleukins: Interleukin-2 (IL-2); Interleukin-6 (IL-6); Interleukin-12 (IL-12)
4) By Vaccines: Preventive Vaccines; Therapeutic Vaccines
5) By Checkpoint Inhibitors: PD-1 Inhibitors; PD-L1 Inhibitors; CTLA-4 Inhibitors
6) By Other Types: Cancer Cell Therapies; Cytokine Therapy; T-Cell Receptor Therapy
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Novartis AG; Amgen Inc.; AbbVie Inc.; Merck & Co. Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
250 Pages
- 1. Executive Summary
- 2. Drugs for Immunotherapy Market Characteristics
- 3. Drugs for Immunotherapy Market Trends And Strategies
- 4. Drugs for Immunotherapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
- 5. Global Drugs for Immunotherapy Growth Analysis And Strategic Analysis Framework
- 5.1. Global Drugs for Immunotherapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Drugs for Immunotherapy Market Growth Rate Analysis
- 5.4. Global Drugs for Immunotherapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Drugs for Immunotherapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Drugs for Immunotherapy Total Addressable Market (TAM)
- 6. Drugs for Immunotherapy Market Segmentation
- 6.1. Global Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Monoclonal Antibodies
- Interferons
- Interleukins
- Vaccines
- Checkpoint Inhibitors
- Other Types
- 6.2. Global Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cancer
- Autoimmune & Inflammatory Diseases
- Infectious Diseases
- Other Therapy Areas
- 6.3. Global Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Other End Users
- 6.4. Global Drugs for Immunotherapy Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Naked Monoclonal Antibodies
- Conjugated Monoclonal Antibodies
- Bispecific Monoclonal Antibodies
- 6.5. Global Drugs for Immunotherapy Market, Sub-Segmentation Of Interferons, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Interferon Alfa
- Interferon Beta
- Interferon Gamma
- 6.6. Global Drugs for Immunotherapy Market, Sub-Segmentation Of Interleukins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Interleukin-2 (IL-2)
- Interleukin-6 (IL-6)
- Interleukin-12 (IL-12)
- 6.7. Global Drugs for Immunotherapy Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Preventive Vaccines
- Therapeutic Vaccines
- 6.8. Global Drugs for Immunotherapy Market, Sub-Segmentation Of Checkpoint Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- PD-1 Inhibitors
- PD-L1 Inhibitors
- CTLA-4 Inhibitors
- 6.9. Global Drugs for Immunotherapy Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cancer Cell Therapies
- Cytokine Therapy
- T-Cell Receptor Therapy
- 7. Drugs for Immunotherapy Market Regional And Country Analysis
- 7.1. Global Drugs for Immunotherapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Drugs for Immunotherapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Drugs for Immunotherapy Market
- 8.1. Asia-Pacific Drugs for Immunotherapy Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Drugs for Immunotherapy Market
- 9.1. China Drugs for Immunotherapy Market Overview
- 9.2. China Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Drugs for Immunotherapy Market
- 10.1. India Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Drugs for Immunotherapy Market
- 11.1. Japan Drugs for Immunotherapy Market Overview
- 11.2. Japan Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Drugs for Immunotherapy Market
- 12.1. Australia Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Drugs for Immunotherapy Market
- 13.1. Indonesia Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Drugs for Immunotherapy Market
- 14.1. South Korea Drugs for Immunotherapy Market Overview
- 14.2. South Korea Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Drugs for Immunotherapy Market
- 15.1. Western Europe Drugs for Immunotherapy Market Overview
- 15.2. Western Europe Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Drugs for Immunotherapy Market
- 16.1. UK Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Drugs for Immunotherapy Market
- 17.1. Germany Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Drugs for Immunotherapy Market
- 18.1. France Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Drugs for Immunotherapy Market
- 19.1. Italy Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Drugs for Immunotherapy Market
- 20.1. Spain Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Drugs for Immunotherapy Market
- 21.1. Eastern Europe Drugs for Immunotherapy Market Overview
- 21.2. Eastern Europe Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Drugs for Immunotherapy Market
- 22.1. Russia Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Drugs for Immunotherapy Market
- 23.1. North America Drugs for Immunotherapy Market Overview
- 23.2. North America Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Drugs for Immunotherapy Market
- 24.1. USA Drugs for Immunotherapy Market Overview
- 24.2. USA Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Drugs for Immunotherapy Market
- 25.1. Canada Drugs for Immunotherapy Market Overview
- 25.2. Canada Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Drugs for Immunotherapy Market
- 26.1. South America Drugs for Immunotherapy Market Overview
- 26.2. South America Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Drugs for Immunotherapy Market
- 27.1. Brazil Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Drugs for Immunotherapy Market
- 28.1. Middle East Drugs for Immunotherapy Market Overview
- 28.2. Middle East Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Drugs for Immunotherapy Market
- 29.1. Africa Drugs for Immunotherapy Market Overview
- 29.2. Africa Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Drugs for Immunotherapy Market Competitive Landscape And Company Profiles
- 30.1. Drugs for Immunotherapy Market Competitive Landscape
- 30.2. Drugs for Immunotherapy Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 31. Drugs for Immunotherapy Market Other Major And Innovative Companies
- 31.1. GlaxoSmithKline plc
- 31.2. Eli Lilly and Company
- 31.3. Bristol-Myers Squibb
- 31.4. AstraZeneca plc
- 31.5. Johnson & Johnson
- 31.6. UbiVac
- 31.7. Pfizer Inc.
- 31.8. Sanofi SA
- 31.9. Bayer AG
- 31.10. Celgene Corporation
- 31.11. Incyte Corporation
- 31.12. Juno Therapeutics Inc.
- 31.13. Bluebird bio
- 31.14. Celldex Therapeutics
- 31.15. BeiGene
- 32. Global Drugs for Immunotherapy Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Drugs for Immunotherapy Market
- 34. Recent Developments In The Drugs for Immunotherapy Market
- 35. Drugs for Immunotherapy Market High Potential Countries, Segments and Strategies
- 35.1 Drugs for Immunotherapy Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Drugs for Immunotherapy Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Drugs for Immunotherapy Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.